Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Mark J. Ratain

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Ratain, Mark J.

Item TypeName
Concept Phenylurea Compounds
Academic Article Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
Academic Article Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Academic Article Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor.
Academic Article Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
Academic Article Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension.
Academic Article Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.
Academic Article Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.
Academic Article Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment.
Academic Article A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.
Academic Article Resampling phase III data to assess phase II trial designs and endpoints.
Academic Article Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial.
Academic Article Two drug interaction studies of sirolimus in combination with sorafenib or sunitinib in patients with advanced malignancies.
Academic Article Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Academic Article Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies.
Academic Article Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis.
Academic Article Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial.

Search Criteria
  • Phenylurea Compounds